Literature DB >> 11905806

Microarray and histopathological analysis of tumours: the future and the past?

S R Lakhani1, A Ashworth.   

Abstract

The excitement surrounding the development of DNA microarray analysis and proteomics has raised questions about the role of these techniques in clinical practice and patient management. But how did the traditional methods of cancer diagnosis and prognosis develop, and how can high-throughput techniques contribute?

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11905806     DOI： 10.1038/35101087

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  30 in total

1.  Network-based Prediction of Cancer under Genetic Storm.

Authors:  Ahmet Ay; Dihong Gong; Tamer Kahveci
Journal:  Cancer Inform       Date:  2014-10-15

2.  Transcriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma.

Authors:  Xue-Nong Li; Yan-Qing Ding; Guo-Bing Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  Extending the utility of gene profiling data by bridging microarray platforms.

Authors:  Gregory Z Ferl; John M Timmerman; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

4.  Balanced-PCR amplification allows unbiased identification of genomic copy changes in minute cell and tissue samples.

Authors:  Gang Wang; Cameron Brennan; Martha Rook; Jia Liu Wolfe; Christopher Leo; Lynda Chin; Hongjie Pan; Wei-Hua Liu; Brendan Price; G Mike Makrigiorgos
Journal:  Nucleic Acids Res       Date:  2004-05-21       Impact factor: 16.971

5.  A clinical prognostic prediction of lymph node-negative breast cancer by gene expression profiles.

Authors:  Dingfeng Jiang; Naiqing Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-08       Impact factor: 4.553

6.  Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers.

Authors:  Ovidiu C Andronesi; Konstantinos D Blekas; Dionyssios Mintzopoulos; Loukas Astrakas; Peter M Black; A Aria Tzika
Journal:  Int J Oncol       Date:  2008-11       Impact factor: 5.650

7.  Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.

Authors:  Anne M Mills; Andrew H Beck; Kelli D Montgomery; Shirley X Zhu; Inigo Espinosa; Cheng-Han Lee; Subbaya Subramanian; Christopher D Fletcher; Matt van de Rijn; Robert B West
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

8.  Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.

Authors:  Elai Davicioni; Michael J Anderson; Friedrich Graf Finckenstein; James C Lynch; Stephen J Qualman; Hiroyuki Shimada; Deborah E Schofield; Jonathan D Buckley; William H Meyer; Poul H B Sorensen; Timothy J Triche
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

9.  Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.

Authors:  A H Beck; C-H Lee; D M Witten; B C Gleason; B Edris; I Espinosa; S Zhu; R Li; K D Montgomery; R J Marinelli; R Tibshirani; T Hastie; D M Jablons; B P Rubin; C D Fletcher; R B West; M van de Rijn
Journal:  Oncogene       Date:  2009-11-09       Impact factor: 9.867

10.  3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.

Authors:  Andrew H Beck; Ziming Weng; Daniela M Witten; Shirley Zhu; Joseph W Foley; Phil Lacroute; Cheryl L Smith; Robert Tibshirani; Matt van de Rijn; Arend Sidow; Robert B West
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.